Researchers found that chronic inflammation, known as “inflammaging,” could signal health risks long before symptoms appear. This discovery is at the heart of a landmark conference hosted by GlycanAge, aiming to translate 25 years of research into practical tools for both doctors and patients. By analyzing tiny sugar molecules called glycans in the blood, GlycanAge claims it can detect shifts toward inflammation that may indicate an increased risk of diseases like diabetes, heart attacks, and strokes, potentially up to a decade before they manifest.

This is significant for anyone interested in aging well. By identifying inflammation early, you may be able to adjust your lifestyle to prevent serious health issues. For example, if you know that certain glycan patterns suggest you are at risk of developing diabetes, you can take proactive steps to improve your diet and exercise habits. This approach shifts the focus of healthcare from merely reacting to illnesses to anticipating and preventing them.

The conference, co-organized with the Mayo Clinic, will gather leading scientists and clinicians to discuss how to apply this research in clinical settings. While GlycanAge has already analyzed glycan profiles from over 300,000 people, the technology is still in the early stages of widespread clinical application. The effectiveness of these tests in everyday medical practice remains to be fully validated, but the potential for early intervention is promising.

As this research develops, it could reshape how we think about aging and health. Instead of waiting for symptoms to appear, we may soon have the tools to monitor our biological age and inflammation levels, allowing us to make informed lifestyle choices that could extend our healthy years.

Source: longevity.technology